Skip to main content

Advertisement

SpringerLink
Log in

MOG antibody-positive paraneoplastic myelopathy in breast carcinoma: the new culprit

  • Letter to the Editor
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Flanagan EP, McKeon A, Lennon VA et al (2011) Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology 76(24):2089–2095

    Article  CAS  PubMed  Google Scholar 

  2. Flanagan EP, Keegan BM (2013) Paraneoplastic myelopathy. NeurolClin 31(1):307–318

    Google Scholar 

  3. Cherian A, Divya KP, Shetty SC, Kannoth S, Thomas B (2020) Coexistent MOG, NMDAR, CASPR2 antibody positivity: Triumph over the triumvirate. Mult Scler Relat Disord 46:102468

    Article  PubMed  Google Scholar 

  4. Graus F, Delattre JY, Antoine JC et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J NeurolNeurosurg Psychiatry 75:1135–1140

    Article  CAS  Google Scholar 

  5. Pittock SJ, Lennon VA (2008) Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol 65(5):629–632 (published correction appears in Arch Neurol. 2008 Oct;65(10):1394)

    Article  PubMed  Google Scholar 

  6. Keegan BM, Pittock SJ, Lennon VA (2008) Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G. Ann Neurol 63(4):531–534

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananathapuram, Kerala, 695011, India

    Ajith Cherian, Sharath Chandra Shetty, K. P. Divya, Harini Pavuluri & Naveen Kumar Paramasivan

  2. Department of Medical Oncology, Regional Cancer Centre, Thiruvananathapuram, Kerala, 695011, India

    Pranab Karipody Prabhakaran

Authors
  1. Ajith Cherian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharath Chandra Shetty
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. P. Divya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pranab Karipody Prabhakaran
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Harini Pavuluri
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Naveen Kumar Paramasivan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. P. Divya.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interest.

Ethical approval

Ethical approval from the institutional review board was not required for this study.

Informed consent

Formal consent was taken from the patient.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cherian, A., Shetty, S.C., Divya, K.P. et al. MOG antibody-positive paraneoplastic myelopathy in breast carcinoma: the new culprit. Acta Neurol Belg 122, 1603–1605 (2022). https://doi.org/10.1007/s13760-021-01602-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-021-01602-8

Search

Navigation